Total Payments
$2,463
2024 Payments
$799.43
Companies
14
Transactions
65
Medicare Patients
1,746
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$2,463 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,463 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $589.02 | 15 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $425.73 | 6 | $0 (2024) |
| ABBVIE INC. | $283.55 | 7 | $0 (2023) |
| Amgen Inc. | $246.15 | 9 | $0 (2024) |
| PFIZER INC. | $192.52 | 10 | $0 (2024) |
| Horizon Therapeutics plc | $182.49 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $170.76 | 3 | $0 (2024) |
| TG Therapeutics, Inc. | $103.88 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $103.04 | 1 | $0 (2024) |
| Lundbeck LLC | $88.22 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $799.43 | 22 | Amgen Inc. ($157.95) |
| 2023 | $671.80 | 17 | Horizon Therapeutics plc ($152.24) |
| 2022 | $364.09 | 8 | ABBVIE INC. ($162.17) |
| 2021 | $627.68 | 18 | Genentech USA, Inc. ($243.18) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 10/16/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Neurology | ||||||
| 10/15/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $103.04 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.84 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/29/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Bone Health | ||||||
| 06/13/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 06/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: Bone Health | ||||||
| 05/16/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $129.74 | General |
| 05/08/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 04/29/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Rare Disease | ||||||
| 03/28/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 03/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Bone Health | ||||||
| 02/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/08/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Immunology | ||||||
| 02/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.16 | General |
| Category: NEUROLOGY | ||||||
| 02/01/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 12/12/2023 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.46 | General |
| 11/09/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $79.97 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 771 | 114,692 | $4.6M | $876,929 |
| 2022 | 7 | 437 | 25,619 | $995,934 | $297,334 |
| 2021 | 5 | 335 | 40,948 | $1.3M | $395,113 |
| 2020 | 5 | 203 | 18,672 | $653,705 | $174,772 |
Total Patients
1,746
Total Services
199,931
Medicare Billing
$1.7M
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 211 | 21,660 | $1.4M | $398,371 | 28.8% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 33 | 38,640 | $1.0M | $306,057 | 30.5% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 14 | 36,000 | $2.0M | $141,116 | 6.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 94 | 286 | $104,005 | $10,511 | 10.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 21 | 84 | $21,778 | $6,213 | 28.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 258 | 643 | $24,032 | $5,455 | 22.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 64 | 271 | $9,879 | $3,274 | 33.1% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 21 | 16,800 | $20,160 | $2,698 | 13.4% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 17 | 118 | $6,435 | $1,967 | 30.6% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 38 | 190 | $31,344 | $1,268 | 4.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 139 | 9,840 | $571,778 | $170,073 | 29.7% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2022 | 25 | 15,120 | $354,661 | $113,075 | 31.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 15 | 59 | $15,458 | $4,583 | 29.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 40 | 104 | $35,464 | $4,041 | 11.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 171 | 269 | $8,608 | $2,363 | 27.5% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 32 | 140 | $5,180 | $1,752 | 33.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 15 | 87 | $4,785 | $1,446 | 30.2% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2021 | 23 | 30,450 | $690,295 | $222,299 | 32.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 106 | 9,840 | $533,897 | $161,652 | 30.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 39 | 144 | $51,732 | $5,980 | 11.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 132 | 339 | $10,848 | $2,941 | 27.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis | Office | 2021 | 35 | 175 | $7,850 | $2,241 | 28.6% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2020 | 12 | 14,280 | $366,825 | $102,936 | 28.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 50 | 3,720 | $226,745 | $58,462 | 25.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2020 | 38 | 179 | $33,822 | $7,524 | 22.2% |
About Heather Hontzas
Heather Hontzas is a Nurse Practitioner healthcare provider based in Madison, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1083266779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Hontzas has received a total of $2,463 in payments from pharmaceutical and medical device companies, with $799.43 received in 2024. These payments were reported across 65 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,463).
As a Medicare-enrolled provider, Hontzas has provided services to 1,746 Medicare beneficiaries, totaling 199,931 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Madison, MS
- Active Since 07/12/2019
- Last Updated 07/12/2019
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1083266779
Products in Payments
- OCREVUS (Biological) $372.78
- SKYRIZI (Biological) $232.06
- EVENITY (Biological) $226.45
- Ocrevus (Biological) $199.48
- KRYSTEXXA (Biological) $155.24
- ENTYVIO (Biological) $146.80
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $139.16
- BRIUMVI (Drug) $103.88
- TREMFYA (Drug) $103.04
- VYEPTI (Biological) $88.22
- INFLECTRA (Biological) $41.63
- ULTOMIRIS (Biological) $40.29
- DALVANCE (Drug) $33.11
- TEPEZZA (Drug) $27.25
- CUVITRU (Biological) $23.96
- Monoferric (Drug) $22.23
- ADUHELM (Biological) $20.91
- AVYCAZ (Drug) $18.38
- Ocrevus Zunovo (Biological) $16.76
- Rystiggo (Drug) $16.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Madison
Madeleine Wentzel, Dnp, Apnp, Cnm, Fnp, DNP, APNP, CNM, FNP
Nurse Practitioner — Payments: $13,230
Nurse Practitioner $13,230
Emily Meyer, Np, NP
Nurse Practitioner — Payments: $7,476
Nurse Practitioner $7,476
Dr. Jessica Bothun, Dnp, Aprn, Agpcnp-Bc, DNP, APRN, AGPCNP-BC
Nurse Practitioner — Payments: $4,326
Nurse Practitioner $4,326
Catherine Clingan, Np, NP
Nurse Practitioner — Payments: $4,128
Nurse Practitioner $4,128
Jill Phillips
Nurse Practitioner — Payments: $3,928
Nurse Practitioner $3,928
Mrs. Mary Martin, Fnp, FNP
Nurse Practitioner — Payments: $2,941
Nurse Practitioner $2,941